TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully than that to Infliximab/Adalimumab in Spondyloarthritis.
about
Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasis.Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells.Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFα therapy.Association of HLA-B27 with ankylosing spondylitis and clinical features of the HLA-B27-associated ankylosing spondylitis: a meta-analysis.
P2860
TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully than that to Infliximab/Adalimumab in Spondyloarthritis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TNF-α Promoter Polymorphisms P ...... alimumab in Spondyloarthritis.
@en
TNF-α Promoter Polymorphisms P ...... alimumab in Spondyloarthritis.
@nl
type
label
TNF-α Promoter Polymorphisms P ...... alimumab in Spondyloarthritis.
@en
TNF-α Promoter Polymorphisms P ...... alimumab in Spondyloarthritis.
@nl
prefLabel
TNF-α Promoter Polymorphisms P ...... alimumab in Spondyloarthritis.
@en
TNF-α Promoter Polymorphisms P ...... alimumab in Spondyloarthritis.
@nl
P2093
P2860
P31
P921
P356
P1433
P1476
TNF-α Promoter Polymorphisms P ...... alimumab in Spondyloarthritis.
@en
P2093
Dongbao Zhao
Jiucun Wang
P2860
P2888
P356
10.1038/SREP32202
P407
P5008
P577
2016-08-31T00:00:00Z